Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia.

Emadi A, Kapadia B, Bollino D, Bhandary B, Baer MR, Niyongere S, Strovel ET, Kaizer H, Chang E, Choi EY, Ma X, Tighe KM, Carter-Cooper B, Moses BS, Civin CI, Mahurkar A, Shetty AC, Gartenhaus RB, Kamangar F, Lapidus RG. Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia. Leukemia. 2021 07; 35(7):1907-1924.

View in: PubMed

subject areas

Animals
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Cell Line, Tumor
Female
HL-60 Cells
Humans
K562 Cells
Leukemia, Myeloid, Acute
Male
Mice
Mice, Inbred NOD
Proto-Oncogene Proteins c-bcl-2
Sulfonamides
U937 Cells

authors with profiles

Farin Kamangar

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support